Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.81
+0.10 (1.75%)
At close: Apr 17, 2026, 4:00 PM EDT
5.82
+0.01 (0.17%)
After-hours: Apr 17, 2026, 6:24 PM EDT
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $551.26 million as of April 17, 2026. Its market cap has increased by 589.08% in one year.
Market Cap
551.26M
Enterprise Value
441.85M
1-Year Change
589.08%
Ranking
Category
Stock Price
$5.81
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $551.26M, an increase of 229.45%. That is a compound annual growth rate of 29.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 551.26M | 61.79% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 569.13M |
| Lyell Immunopharma | 560.11M |
| Tectonic Therapeutic | 554.10M |
| AgomAb Therapeutics NV | 552.19M |
| Fulcrum Therapeutics | 552.12M |
| Immix Biopharma | 548.68M |
| Absci | 547.82M |
| ADC Therapeutics | 543.75M |